• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Salix Pharmaceuticals Ltd

+ Add to Watchlist

SLXP:US

135.5600 USD 2.0500 1.49%

As of 20:10:00 ET on 10/23/2014.

Snapshot for Salix Pharmaceuticals Ltd (SLXP)

Open: 139.2200 Day's Range: 135.0900 - 140.2500 Volume: 1,289,362
Previous Close: 137.6100 52wk Range: 70.6400 - 172.9800 1-Yr Rtn: +84.16%

Stock Chart for SLXP

No chart data available.
  • SLXP:US 135.8000
  • 1D
  • 1M
  • 1Y
137.6100
Interactive SLXP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLXP

Current P/E Ratio (ttm) 75.7096
Estimated P/E(12/2014) 22.0136
Relative P/E vs. SPX 4.3559
Earnings Per Share (USD) (ttm) 1.7905
Est. EPS (USD) (12/2014) 6.1580
Est. PEG Ratio 0.9687
Market Cap (M USD) 8,633.66
Shares Outstanding (M) 63.69
30 Day Average Volume 2,445,096
Price/Book (mrq) 11.6919
Price/Sale (ttm) 6.7633
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLXP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SLXP

Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.

Carolyn J LoganPresident/CEOAdam C DerbyshireExec VP:Finance & Admin/CFO
William P ForbesExec VP:Research & DevRick D ScruggsExec VP:Business Development
More Company Profile & Key Executives for SLXP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil